Back to today’s briefing

Story perspectives

Weight Loss Drug Shortages Spark Safety Concerns and Risks

5/14/2025

32 6

Summary

Story summary

GLP-1 agonist drugs, originally designed for type 2 diabetes, are now sought after for weight loss, causing shortages and off-label use. With only three out of ten approved for obesity, many patients resort to illegal online pharmacies, jeopardizing their safety. It's crucial for prescribers to inform patients about these risks and promote safe sourcing.

1 of 1

Story summary

GLP-1 agonist drugs, originally designed for type 2 diabetes, are now sought after for weight loss, causing shortages and off-label use. With only three out of ten approved for obesity, many patients resort to illegal online pharmacies, jeopardizing their safety. It's crucial for prescribers to inform patients about these risks and promote safe sourcing.